🇺🇸 Ganforti in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 9

Most-reported reactions

1. Blindness — 1 report (11.11%)
2. Condition Aggravated — 1 report (11.11%)
3. Diabetes Mellitus Inadequate Control — 1 report (11.11%)
4. Diabetic Retinopathy — 1 report (11.11%)
5. Gastritis — 1 report (11.11%)
6. Lymphangitis — 1 report (11.11%)
7. Motor Dysfunction — 1 report (11.11%)
8. Superficial Vein Thrombosis — 1 report (11.11%)
9. Vomiting — 1 report (11.11%)

Source database →

Frequently asked questions

Is Ganforti approved in United States?

Ganforti does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ganforti in United States?

Allergan S.A. DE C.V.. is the originator. The local marketing authorisation holder may differ — check the official source linked above.